UNC working with Mass. pharma company on depression drug

Researchers at the University of North Carolina School of Medicine are working with Cambridge, Massachusetts-based biopharmaceutical company Sage Therapeutics (Nasdaq: SAGE) on clinical trials of a drug for the treatment of severe postpartum depression (PPD). A multi-site Phase 3 trial for the drug called brexanolone is currently underway at the Perinatal Psychiatry Program at the UNC School of Medicine and promising results of a Phase 2 trial were published this week in The Lancet medical journal. “We…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news